Genomic profiling of idiopathic peri-hilar cholangiocarcinoma reveals new targets and mutational pathways (2023)

First Author: Quinn L

Attributed to: Centre for Drug Safety Science (CDSS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41598-023-33096-0

Publication URI: http://dx.doi.org/10.1038/s41598-023-33096-0

Type: Journal Article/Review

Parent Publication: Scientific Reports

Issue: 1